Yuki Gosei Kogyo Co., Ltd. Reports Non-Consolidated Earnings Results for the Year Ended March 31, 2019; Provides Earnings Guidance for the First Half and Full year of Fiscal Year Ending March 31, 2020
May 15, 2019 at 12:00 am EDT
Share
Yuki Gosei Kogyo Co., Ltd. reported non-consolidated earnings results for the year ended March 31, 2019. For the period, the company reported net sales of JPY 10,272 million against JPY 10,073 million a year ago. Operating income was JPY 49 million against JPY 205 million a year ago. Net income was JPY 104 million against JPY 125 million a year ago. Net income per share was JPY 4.78 against JPY 5.74 a year ago.
For the first half of fiscal year ending March 31, 2020, the non-consolidated company expected net sales of JPY 5,300 million, operating income of JPY 50 million and net income of JPY 20 million or net income per share of JPY 0.91.
For the year ending March 31, 2020, the non-consolidated company expected net sales of JPY 10,900 million, operating income of JPY 140 million and net income of JPY 90 million or net income per share of JPY 4.12.
Yuki Gosei Kogyo Co., Ltd. is a Japan-based company mainly engaged in the manufacture and sale of amino acids, chemicals and pharmaceuticals. The amino acids business is involved in the manufacture and sale of amino acids and vitamin ingredients. The chemical products business in involved in the manufacture and sale of the tire cord adhesive raw materials, agricultural chemical intermediates, silicon compounds and other products. The pharmaceuticals business is involved in the manufacture and sale of the pharmaceutical raw materials and intermediates. The commission of manufacture operation business is involved in the contract for manufacture operations through subsidiaries. The Company is also involved in the manufacture and sale of foods, food additives, feed additives, fragrances, and cosmetics, as well as the sale of the related raw materials and products.
Yuki Gosei Kogyo Co., Ltd. Reports Non-Consolidated Earnings Results for the Year Ended March 31, 2019; Provides Earnings Guidance for the First Half and Full year of Fiscal Year Ending March 31, 2020